Vanguard Group’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$37.8M Buy
7,475,477
+541,973
+8% +$2.52M ﹤0.01% 2316
2025
Q3
$24.1M Sell
6,933,504
-831,634
-11% -$3.12M ﹤0.01% 2536
2025
Q2
$26.4M Sell
7,765,138
-1,856,870
-19% -$6.19M ﹤0.01% 2429
2025
Q1
$38.6M Sell
9,622,008
-2,094,835
-18% -$10.9M ﹤0.01% 2207
2024
Q4
$76M Sell
11,716,843
-61,211
-0.5% -$365K ﹤0.01% 1979
2024
Q3
$65.3M Buy
11,778,054
+31,876
+0.3% +$181K ﹤0.01% 2065
2024
Q2
$65.5M Sell
11,746,178
-266,627
-2% -$1.6M ﹤0.01% 2043
2024
Q1
$80.6M Buy
12,012,805
+122,105
+1% +$966K ﹤0.01% 1968
2023
Q4
$108M Buy
11,890,700
+811,279
+7% +$5.11M ﹤0.01% 1825
2023
Q3
$61.2M Buy
11,079,421
+461,142
+4% +$3.7M ﹤0.01% 2035
2023
Q2
$90.7M Buy
10,618,279
+2,732,791
+35% +$24.5M ﹤0.01% 1908
2023
Q1
$72.5M Buy
7,885,488
+114,421
+1% +$1.23M ﹤0.01% 1990
2022
Q4
$79.3M Buy
7,771,067
+83,562
+1% +$1.12M ﹤0.01% 1932
2022
Q3
$113M Buy
7,687,505
+1,413,703
+23% +$18.4M ﹤0.01% 1716
2022
Q2
$67.3M Sell
6,273,802
-78,288
-1% -$779K ﹤0.01% 2045
2022
Q1
$68.5M Buy
6,352,090
+5,140,344
+424% +$69.4M ﹤0.01% 2140
2021
Q4
$19.8M Buy
1,211,746
+15,374
+1% +$322K ﹤0.01% 2847
2021
Q3
$25.6M Buy
+1,196,372
New +$28.1M ﹤0.01% 2711

Other funds holding CTKB